Targeting Immune Modulators in Glioma While Avoiding Autoimmune Conditions.

Bitar, Lynn; Schumann, Ulrike; König, Renate; Zipp, Frauke; Schmidt, Mirko H H

Bitar, Lynn; Schumann, Ulrike; König, Renate; Zipp, Frauke; Schmidt, Mirko H H.

Afiliação

Bitar L; Department of Neurology, Focus Program Translational Neuroscience (FTN) and Immunotherapy (FZI), Rhine Main Neuroscience Network, University Medical Center of The Johannes Gutenberg University Mainz, 55131 Mainz, Germany.
Schumann U; Institute of Anatomy, Medical Faculty Carl Gustav Carus, Technische Universität Dresden School of Medicine, 01307 Dresden, Germany.
König R; Host-Pathogen Interactions, Paul-Ehrlich-Institute, 63225 Langen, Germany.
Zipp F; Department of Neurology, Focus Program Translational Neuroscience (FTN) and Immunotherapy (FZI), Rhine Main Neuroscience Network, University Medical Center of The Johannes Gutenberg University Mainz, 55131 Mainz, Germany.
Schmidt MHH; Institute of Anatomy, Medical Faculty Carl Gustav Carus, Technische Universität Dresden School of Medicine, 01307 Dresden, Germany.

Cancers (Basel) ; 13(14)2021 Jul 14.

Article em En | MEDLINE | ID: mdl-34298735

Palavras-chave

autoimmune disease; clinical trials; glioma; immune checkpoints; immunotherapy

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google